Company intelligence / Profile preview

PBM Capital Group

Charlottesville, Virginia, United Statespbmcap.com ↗

Ownership: Private
Development stage: Other

Overview

PBM Capital has enabled several successful IPOs and acquisitions among its healthcare/life science portfolio companies, including AveXis (acquired by Novartis), Dova Pharmaceuticals, and Verrica Pharmaceuticals[1].

Industry: Investors

Partnerships

Strategic partnerships with scientists, engineers, entrepreneurs through investments in their ventures. No direct pharma/biotech co-development partnerships as an operating entity.

Beyond the preview

Go deeper on PBM Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PBM Capital Group.

Explore the full profile